Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction
(Q46937459)
scientific article published on 9 February 2006
scientific article published on 9 February 2006
Language:
Current Data About
Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction